These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 27226215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT, Perng CL, Chou YC, Ko PS, Lin YJ, Lin YC, Chang CC, Wang YC, Shang HS, Chao TK.
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [Abstract] [Full Text] [Related]

  • 3. Pyruvate Kinase M2 Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial Carcinoma.
    Lai YJ, Chou YC, Lin YJ, Yu MH, Ou YC, Chu PW, Wu CC, Wang YC, Chao TK.
    Int J Environ Res Public Health; 2019 Nov 20; 16(23):. PubMed ID: 31756939
    [Abstract] [Full Text] [Related]

  • 4. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R, Cavallo A, Lee N, Montag A, Gwin K.
    Int J Gynecol Pathol; 2015 Jan 20; 34(1):65-73. PubMed ID: 25473755
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K, Ertas IE, Sahbaz A, Ozvural S, Sarica Y, Ozdemir A, Sayhan S, Gokcu M, Yilmaz B, Sanci M, Inan S, Harma M, Yildirim Y.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug 20; 179():147-52. PubMed ID: 24965996
    [Abstract] [Full Text] [Related]

  • 7. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change.
    Gurda GT, Baras AS, Kurman RJ.
    Int J Gynecol Pathol; 2014 Mar 20; 33(2):114-9. PubMed ID: 24487464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ, Li XH, Zhang X, Zhang ZY, Meng YL, Xu SW, Zheng Y, Zhu ZL, Cui DS, Huang LX, Yan BY, Sun XF.
    Chemotherapy; 2010 Mar 20; 56(4):291-7. PubMed ID: 20714146
    [Abstract] [Full Text] [Related]

  • 16. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT.
    Hum Reprod Update; 2017 Mar 01; 23(2):232-254. PubMed ID: 27920066
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Using Pyruvate Kinase as a Predictor for Patient With Endometrial Cancer Having Complex Hyperplasia With Atypia to Prevent Hysterectomy and Preserve Fertility: Retrospective Immunohistochemical Study.
    Hosseini Nasab S, Jooya N, Esmaeili A, Zarrin Khameh N, Diaz-Arrastia C, Momeni M.
    Reprod Sci; 2018 Aug 01; 25(8):1286-1291. PubMed ID: 29153060
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.